Vanguard Fiduciary Trust
CSBR icon

Vanguard Fiduciary Trust’s Champions Oncology CSBR Stock Holding History

Vanguard Fiduciary Trust’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$205K Buy
33,239
+247
+0.7% +$1.49K ﹤0.01% 3571
2026
Q1 		$190K Buy
+32,992
New +$210K ﹤0.01% 3533

Other funds holding CSBR

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Fiduciary Trust's CSBR Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Champions Oncology (CSBR) stake by 0.75% in Q2 2026, buying an estimated $1.49K and bringing the position to 33,239 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #3571.

Vanguard Fiduciary Trust first reported a position in CSBR in Q1 2026 and has held it in 2 quarters since. 23 funds tracked by Wall St. Rank hold CSBR as of Q2 2026.

  • Vanguard Fiduciary Trust held 33,239 shares of Champions Oncology worth $205K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 247 Champions Oncology shares in Q2 2026, an estimated $1.49K.
  • Champions Oncology made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3571 holding.
  • Vanguard Fiduciary Trust first reported a position in Champions Oncology in Q1 2026 and has held it in 2 quarters since.
  • 23 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.